Improving treatment for children with perianal Crohn’s disease
Standardization of Evaluation to Treatment of pediatric perianal Crohn’s disease and improving Outcomes through Networking (SETON)
This study is looking at how to improve the treatment of kids with perianal Crohn’s disease by finding better ways to manage their care and reduce the use of antibiotics, so that doctors can help them feel better without unnecessary medications.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11077870 on NIH RePORTER |
What this research studies
This research investigates how to standardize the treatment of pediatric perianal Crohn’s disease, particularly focusing on reducing unnecessary antibiotic use. By collaborating with multiple pediatric institutions, the study aims to develop a protocol that guides healthcare providers in managing this condition more effectively. The approach includes a multidisciplinary team of specialists who will collect data on current practices and identify barriers to optimal care. The goal is to enhance patient outcomes by minimizing complications associated with antibiotic overuse and improving overall treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are children diagnosed with perianal Crohn’s disease who are currently receiving treatment.
Not a fit: Patients without a diagnosis of Crohn’s disease or those who do not have perianal complications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better management of pediatric perianal Crohn’s disease, reducing complications and improving quality of life for affected children.
How similar studies have performed: Previous research has shown that standardizing treatment protocols can lead to improved patient outcomes, suggesting that this approach may be effective.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Adler, Jeremy — University of Michigan at Ann Arbor
- Study coordinator: Adler, Jeremy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.